Account Info
Log Out
English
Back
Log in to access Online Inquiry
Back to the Top

$Entera Bio (ENTX.US)$ Entera Bio Announces Robust Pharmacok...

$Entera Bio (ENTX.US)$ Entera Bio Announces Robust Pharmacokinetic Data for First-in-Class Oral GLP-2 Peptide Tablet Treatment for Patients with Short Bowel Syndrome
1 MINUTE AGO, 8:00 AM EDT
VIA GLOBENEWSWIRE
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more
Translate
Report
4938 Views
Comment
Sign in to post a comment